Tuberculosis (TB) remains one of the leading public health problems worldwide. Declared
as a global emergency in 1993 by the WHO, its control is hampered by the emergence of …

Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by
the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the …

Tuberculosis (TB) has become a curable disease, thanks to the discovery of antibiotics.
However, it has remained one of the most difficult infections to treat. Most current TB …

Tuberculosis (TB) is the single largest killer among infectious diseases. The recent
resurgence of TB together with outbreaks of multidrug resistant tuberculosis has focused …

The story of antituberculosis chemotherapy is a miniature of the history of anti-infective
chemotherapy. In the first half of the 20th century the problem of tuberculosis appeared …

Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming
counter attack of TB worldwide. However, when it was known that TB can be cured …

Drug resistance in tuberculosis (TB) is a particular problem because the lengthy therapy of
at least 6 months makes patient compliance very difficult, which frequently creates drug …

Tuberculosis is the leading cause of death from a curable infectious disease and there were
an estimated 8.9 million new cases of tuberculosis in 2004 [1]. Tackling the global burden of …

Anti-tuberculosis drugs are a two-edged sword. While they destroy pathogenic M.
tuberculosis they also select for drug resistant bacteria against which those drugs are then …

Multidrug-resistant strains of Mycobacterium tuberculosis seriously threaten tuberculosis
(TB) control and prevention efforts. Molecular studies of the mechanism of action of …